Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01373814 · ClinicalTrials.gov registry record
Nutritional Therapy for Diabetic Cardiomyopathy
A clinical trial of T2DM (Type 2 Diabetes Mellitus), sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT01373814 is a study of T2DM (Type 2 Diabetes Mellitus) that has completed, run by Washington University School of Medicine. The registered enrollment target is 22 participants, below the 229-participant average among 4 other T2DM (Type 2 Diabetes Mellitus) trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01373814, a study of T2DM (Type 2 Diabetes Mellitus), has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine if nutritional therapy can effectively treat/prevent T2DM and its consequent cardiomyopathy.
Conditions Studied
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-09-03 |
| Est. Completion | 2011-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01373814
The ClinicalTrials.gov registry entry for NCT01373814 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 4 other T2DM (Type 2 Diabetes Mellitus) trials with a reported enrollment target (90% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with T2DM (Type 2 Diabetes Mellitus) appearing as the primary indexed condition, and to 0 interventions.
NCT01373814 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01373814 about?
NCT01373814 is a clinical study titled "Nutritional Therapy for Diabetic Cardiomyopathy". The goal of this study is to determine if nutritional therapy can effectively treat/prevent T2DM and its consequent cardiomyopathy.
What is the current status of trial NCT01373814?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2010-09-03. Estimated completion is 2011-06-17.
What conditions does trial NCT01373814 study?
This clinical trial studies the following conditions: T2DM (Type 2 Diabetes Mellitus).
Who is sponsoring clinical trial NCT01373814?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01373814 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for T2DM (Type 2 Diabetes Mellitus)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine
RECRUITING · NA
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 2
-
Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
RECRUITING
-
Virtual Diabetes Group Visits Across Health Systems
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.